Abalam (Abacavir 600 mg + Lamivudine 300 mg) Tablets – Trusted HIV Treatment Exporter from India
The global demand for high-quality Abacavir 600 mg + Lamivudine 300 mg Tablets continues to rise as countries strengthen HIV/AIDS treatment programs. Abalam Tablets, manufactured and exported by Cordium Pharmaceuticals Pvt. Ltd., are formulated according to international quality standards and are intended for use as part of combination antiretroviral therapy for the treatment of HIV-1 infection.
As a reliable pharmaceutical exporter from India, Cordium Pharmaceuticals supplies Abalam Tablets to regulated and emerging international markets, including Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.
What is Abalam?
Abalam is a fixed-dose combination tablet containing:
Abacavir 600 mg
Lamivudine 300 mg
Both medicines belong to the class of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and are widely used as part of combination antiretroviral therapy (ART) for HIV-1 infection. They are not intended to be used as monotherapy and are combined with other antiretroviral medicines as directed by HIV treatment guidelines.
Mechanism of Action of Abalam Tablets
Abalam works by combining two potent antiviral agents that inhibit HIV replication.
Abacavir 600 mg
Abacavir is converted inside cells into its active metabolite (carbovir triphosphate). This metabolite competes with natural nucleotides during viral DNA synthesis, inhibiting HIV reverse transcriptase and causing premature termination of viral DNA formation.
Lamivudine 300 mg
Lamivudine is phosphorylated intracellularly to its active triphosphate form. It blocks HIV reverse transcriptase by incorporating into viral DNA and terminating DNA chain elongation, thereby suppressing viral replication.
Combined Clinical Benefit
The combination of Abacavir and Lamivudine:
Reduces HIV viral load
Helps increase CD4 cell counts
Slows disease progression
Supports long-term viral suppression when used with other antiretroviral medicines
Improves treatment adherence with once-daily fixed-dose therapy
Uses of Abalam Tablets
Abalam Tablets are indicated as part of combination antiretroviral therapy for:
HIV-1 infection in adults
Adolescents and children weighing at least 25 kg (according to approved labeling)
Long-term HIV management under physician supervision
National HIV/AIDS treatment programs
Hospital procurement and government tenders
International donor-funded HIV treatment initiatives
Important: Patients should be screened for the HLA-B*5701 allele before initiating Abacavir because carriers are at increased risk of serious hypersensitivity reactions.
Why Choose Cordium Pharmaceuticals Pvt. Ltd.?
Cordium Pharmaceuticals Pvt. Ltd. is a trusted Indian pharmaceutical manufacturer and exporter offering:
WHO-GMP quality manufacturing
Export-quality antiretroviral medicines
Competitive international pricing
Reliable global supply chain
Bulk orders and institutional supply
Regulatory documentation support
Timely worldwide deliveries
Private labeling and contract manufacturing (where applicable)
Countries We Export Abalam Tablets
Cordium Pharmaceuticals exports Abalam (Abacavir 600 mg + Lamivudine 300 mg) Tablets to:
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇵🇭 Philippines
🇻🇳 Vietnam
🇦🇪 UAE
🇸🇦 Saudi Arabia
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
🇺🇸 USA
🇬🇧 UK
🇿🇦 South Africa
We also welcome distributor inquiries, government tenders, NGO procurement, hospital supply contracts, and importer partnerships across Africa, Asia, the Middle East, Europe, and North America.
The global demand for high-quality Abacavir 600 mg + Lamivudine 300 mg Tablets continues to rise as countries strengthen HIV/AIDS treatment programs. Abalam Tablets, manufactured and exported by Cordium Pharmaceuticals Pvt. Ltd., are formulated according to international quality standards and are intended for use as part of combination antiretroviral therapy for the treatment of HIV-1 infection.
As a reliable pharmaceutical exporter from India, Cordium Pharmaceuticals supplies Abalam Tablets to regulated and emerging international markets, including Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.
What is Abalam?
Abalam is a fixed-dose combination tablet containing:
Abacavir 600 mg
Lamivudine 300 mg
Both medicines belong to the class of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and are widely used as part of combination antiretroviral therapy (ART) for HIV-1 infection. They are not intended to be used as monotherapy and are combined with other antiretroviral medicines as directed by HIV treatment guidelines.
Mechanism of Action of Abalam Tablets
Abalam works by combining two potent antiviral agents that inhibit HIV replication.
Abacavir 600 mg
Abacavir is converted inside cells into its active metabolite (carbovir triphosphate). This metabolite competes with natural nucleotides during viral DNA synthesis, inhibiting HIV reverse transcriptase and causing premature termination of viral DNA formation.
Lamivudine 300 mg
Lamivudine is phosphorylated intracellularly to its active triphosphate form. It blocks HIV reverse transcriptase by incorporating into viral DNA and terminating DNA chain elongation, thereby suppressing viral replication.
Combined Clinical Benefit
The combination of Abacavir and Lamivudine:
Reduces HIV viral load
Helps increase CD4 cell counts
Slows disease progression
Supports long-term viral suppression when used with other antiretroviral medicines
Improves treatment adherence with once-daily fixed-dose therapy
Uses of Abalam Tablets
Abalam Tablets are indicated as part of combination antiretroviral therapy for:
HIV-1 infection in adults
Adolescents and children weighing at least 25 kg (according to approved labeling)
Long-term HIV management under physician supervision
National HIV/AIDS treatment programs
Hospital procurement and government tenders
International donor-funded HIV treatment initiatives
Important: Patients should be screened for the HLA-B*5701 allele before initiating Abacavir because carriers are at increased risk of serious hypersensitivity reactions.
Why Choose Cordium Pharmaceuticals Pvt. Ltd.?
Cordium Pharmaceuticals Pvt. Ltd. is a trusted Indian pharmaceutical manufacturer and exporter offering:
WHO-GMP quality manufacturing
Export-quality antiretroviral medicines
Competitive international pricing
Reliable global supply chain
Bulk orders and institutional supply
Regulatory documentation support
Timely worldwide deliveries
Private labeling and contract manufacturing (where applicable)
Countries We Export Abalam Tablets
Cordium Pharmaceuticals exports Abalam (Abacavir 600 mg + Lamivudine 300 mg) Tablets to:
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇵🇭 Philippines
🇻🇳 Vietnam
🇦🇪 UAE
🇸🇦 Saudi Arabia
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
🇺🇸 USA
🇬🇧 UK
🇿🇦 South Africa
We also welcome distributor inquiries, government tenders, NGO procurement, hospital supply contracts, and importer partnerships across Africa, Asia, the Middle East, Europe, and North America.
Keywords
